183 related articles for article (PubMed ID: 24432377)
1. The development of ternary nanoplexes for efficient small interfering RNA delivery.
Şalva E; Turan SÖ; Akbuğa J
Biol Pharm Bull; 2013; 36(12):1907-14. PubMed ID: 24432377
[TBL] [Abstract][Full Text] [Related]
2. Comparison of VEGF gene silencing efficiencies of chitosan and protamine complexes containing shRNA.
Erdem-Çakmak F; Özbaş-Turan S; Şalva E; Akbuğa J
Cell Biol Int; 2014 Nov; 38(11):1260-70. PubMed ID: 24890139
[TBL] [Abstract][Full Text] [Related]
3. In vitro silencing effect of chitosan nanoplexes containing siRNA expressing vector targeting VEGF in breast cancer cell lines.
Salva E; Akbuğa J
Pharmazie; 2010 Dec; 65(12):896-902. PubMed ID: 21284259
[TBL] [Abstract][Full Text] [Related]
4. The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1α and VEGF.
Şalva E; Turan SÖ; Eren F; Akbuğa J
Int J Pharm; 2015 Jan; 478(1):147-154. PubMed ID: 25445537
[TBL] [Abstract][Full Text] [Related]
5. Efficient intracellular siRNA delivery strategy through rapid and simple two steps mixing involving noncovalent post-PEGylation.
Kong WH; Sung DK; Shim YH; Bae KH; Dubois P; Park TG; Kim JH; Seo SW
J Control Release; 2009 Sep; 138(2):141-7. PubMed ID: 19426771
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of three ternary complexes prepared in different mixing orders of siRNA/redox-responsive hyperbranched poly (amido amine)/hyaluronic acid.
Chen CJ; Zhao ZX; Wang JC; Zhao EY; Gao LY; Zhou SF; Liu XY; Lu WL; Zhang Q
Int J Nanomedicine; 2012; 7():3837-49. PubMed ID: 22888238
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Glomerular Mesangial Cell Proliferation by siPDGF-B- and siPDGFR-β-Containing Chitosan Nanoplexes.
Salva E; Turan SÖ; Akbuğa J
AAPS PharmSciTech; 2017 May; 18(4):1031-1042. PubMed ID: 27975193
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-based hybrid nanocomplex for siRNA delivery and its application for cancer therapy.
Ki MH; Kim JE; Lee YN; Noh SM; An SW; Cho HJ; Kim DD
Pharm Res; 2014 Dec; 31(12):3323-34. PubMed ID: 24858398
[TBL] [Abstract][Full Text] [Related]
9. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.
Darvishi MH; Nomani A; Amini M; Shokrgozar MA; Dinarvand R
Int J Pharm; 2013 Nov; 456(2):408-16. PubMed ID: 24012865
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid/chitosan multilayer coatings on neuronal implants for localized delivery of siRNA nanoplexes.
Hartmann H; Hossfeld S; Schlosshauer B; Mittnacht U; Pêgo AP; Dauner M; Doser M; Stoll D; Krastev R
J Control Release; 2013 Jun; 168(3):289-97. PubMed ID: 23562632
[TBL] [Abstract][Full Text] [Related]
11. Novel siRNA delivery system using a ternary polymer complex with strong silencing effect and no cytotoxicity.
Kodama Y; Shiokawa Y; Nakamura T; Kurosaki T; Aki K; Nakagawa H; Muro T; Kitahara T; Higuchi N; Sasaki H
Biol Pharm Bull; 2014; 37(8):1274-81. PubMed ID: 25087949
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cellular uptake and gene silencing activity of siRNA molecules mediated by chitosan-derivative nanocomplexes.
Guzman-Villanueva D; El-Sherbiny IM; Vlassov AV; Herrera-Ruiz D; Smyth HD
Int J Pharm; 2014 Oct; 473(1-2):579-90. PubMed ID: 25063077
[TBL] [Abstract][Full Text] [Related]
13. Binary and ternary complexes based on polycaprolactone-graft-poly (N, N-dimethylaminoethyl methacrylate) for targeted siRNA delivery.
Huang Y; Lin D; Jiang Q; Zhang W; Guo S; Xiao P; Zheng S; Wang X; Chen H; Zhang HY; Deng L; Xing J; Du Q; Dong A; Liang Z
Biomaterials; 2012 Jun; 33(18):4653-64. PubMed ID: 22480869
[TBL] [Abstract][Full Text] [Related]
14. Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene delivery.
He SN; Li YL; Yan JJ; Zhang W; Du YZ; Yu HY; Hu FQ; Yuan H
Int J Nanomedicine; 2013; 8():2859-69. PubMed ID: 23990715
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.
Lee SJ; Yook S; Yhee JY; Yoon HY; Kim MG; Ku SH; Kim SH; Park JH; Jeong JH; Kwon IC; Lee S; Lee H; Kim K
J Control Release; 2015 Dec; 220(Pt B):631-41. PubMed ID: 26307351
[TBL] [Abstract][Full Text] [Related]
16. Nanocomposite-siRNA approach for down-regulation of VEGF and its receptor in myeloid leukemia cells.
Wang L; Zhang WJ; Xiu B; Ding Y; Li P; Ye WD; Zhu Q; Liang AB
Int J Biol Macromol; 2014 Feb; 63():49-55. PubMed ID: 24183807
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
[TBL] [Abstract][Full Text] [Related]
18. Efficient inhibition of uveal melanoma via ternary siRNA complexes.
Xie L; Yang Y; Shen J
Int J Pharm; 2020 Jan; 573():118894. PubMed ID: 31765784
[TBL] [Abstract][Full Text] [Related]
19. Chitosan as a carrier for targeted delivery of small interfering RNA.
Rudzinski WE; Aminabhavi TM
Int J Pharm; 2010 Oct; 399(1-2):1-11. PubMed ID: 20732398
[TBL] [Abstract][Full Text] [Related]
20. Local delivery of chitosan/VEGF siRNA nanoplexes reduces angiogenesis and growth of breast cancer in vivo.
Salva E; Kabasakal L; Eren F; Ozkan N; Cakalağaoğlu F; Akbuğa J
Nucleic Acid Ther; 2012 Feb; 22(1):40-8. PubMed ID: 22217324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
